Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 1017
Aptamer sequence: UUACAAUGAGGUGGGACGCGGGUUGUGGUG
Target unique ID: Other-34
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_927 TAFapt4 Other leukemic AML1-MTG8 fusion protein 7.76 nM 20 mM sodium phosphate (pH 6.5), 2 mM magnesium acetate, 200 mM potassium acetate, 5% glycerol, 0.05% Triton X-100, 5 mM b-mercaptoethanol 32870501
Structure information of aptamer
Aptamer Sequence: UUACAAUGAGGUGGGACGCGGGUUGUGGUG
The optimal secondary structure in dot-bracket notation: (((((((...(((...)))..)))))))..
The centroid secondary structure in dot-bracket notation: .((((((...(((...)))..))))))...
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_927 Description TAFapt4
Aptamer chemistry RNA Length 30 nt
GC content 56.7% Molecular weight 9,781.82 Da
Molarity of 1 μg/μl solution 102.23 μM Number of G-quadruplexes 2
G-Score 19 Function Targeted therapy
Sequence UUACAAUGAGGUGGGACGCGGGUUGUGGUG
Applications The aptamer could bind to the AML1-MTG8 fusion protein and dissociate the AML1-MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1-MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia
Target information
Type Detail Type Detail
Target ID Other-34 Name leukemic AML1-MTG8 fusion protein
Activity data

No relevant experimental diagram

Interaction ID 1017
Target type Other
Target unique ID Other-34
Activity 7.76 nM
Binding Conditions/Buffer

20 mM sodium phosphate (pH 6.5), 2 mM magnesium acetate, 200 mM potassium acetate, 5% glycerol, 0.05% Triton X-100, 5 mM b-mercaptoethanol

Assay

N/A

PubMed ID 32870501
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_319 RNA ACCCUGAUGGUAGACGCCGGGGUG 60.00%
Apta_1166 RNA GAUGUAACUGAAUGAAAUGGUGAAGGACGGGUCCAGUAGGCUGC 59.09%
Apta_379 RNA UACGACACGAUUGGGACGUGUCUAUGGGAC 56.67%
Apta_1194 DNA GGGAGAGGTGGGAGCGGGGCCAGGG 56.67%
Apta_231 RNA GGGAGGACGAUGCGGGUGUGGGGCG 53.33%
Apta_245 DNA ACAGGGGTGTGGGGACAGGGGTGTGGGG 53.33%
Apta_926 RNA UCGGCAGCGGUUAGAGAGGUGGUGUGCGGG 53.33%
Apta_242 RNA GCUUCCAGGAAGAGAAGUGUCAUGUGAUCAGUCCUGGUGGGUGG 52.27%
Apta_96 RNA UCGCUAAUUAUAGGCGGAGUGCGACGUUAUAAAUA 51.43%
Apta_230 RNA GGGAGGACGAUGCGGGCGUGAAUGGUGUUGUGAGG 51.43%
Apta_11 DNA AGAGGGGGGGGTCGGGGTGGGTCGC 50.00%
Apta_13 DNA AGGGGGGGGGGAGGGGTCGGGGTGG 50.00%
Apta_241 RNA GCUUGACGGAGAUCAAGGGCGAGUCUCAUACCAAGUUGAUGGGG 50.00%
Apta_244 RNA GCUUCCGGAGAGAAGGGUCAAAGUUGUGCGGGAGUGUGUUGUGG 50.00%
Apta_320 DNA GCACTCTGTGGGGGTGGACGGGCCGGGT 50.00%
Apta_402 RNA GCCUGUAAGGUGGUCGGUGUGGCGAGUGUGUUAGGAGAGAUUGC 50.00%
Apta_925 RNA GCUCGGCCAGGUCGCGGGUGGAUGUGAGGG 50.00%
Apta_243 RNA GCUUGAAGCUAGCAGUAAGACUAGCGCUACGGAUGGGUGUGCG 48.84%
Apta_649 DNA GCACACCGATGGCGGTCCTGTTTAGGGGGTGTGCGTG 48.65%
Apta_89 RNA AAUAACCUUAAUGCGACGUUGGUUCGUCAACAUGG 48.57%